Effectiveness and Safety of Lacosamide in Pediatric Patients with Epilepsy Under Four Years: Results from a Prospective Cohort Study in China

Epilepsy is a serious neurological condition, affected over 65 million people worldwide.[1] The median incidence rate of epilepsy is 82.2 per 100,000 in age group 0-14 years, which is higher than the older group.[2] Diagnosing, classifying, and reporting seizure frequency are typically challenges for pediatric patients in clinical practice and research of epilepsy.[3] There are a few placebo-control randomized clinical trials demonstrating efficacy and well tolerance of LCM in adults and adolescents patient.
Source: Seizure: European Journal of Epilepsy - Category: Neurology Authors: Source Type: research